tiprankstipranks
Trending News
More News >
Metlife (MET)
NYSE:MET
US Market
Advertisement

Metlife (MET) Stock Forecast & Price Target

Compare
2,846 Followers
See the Price Targets and Ratings of:

MET Analyst Ratings

Strong Buy
11Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Metlife
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MET Stock 12 Month Forecast

Average Price Target

$96.89
▲(29.48%Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Metlife in the last 3 months. The average price target is $96.89 with a high forecast of $110.00 and a low forecast of $90.00. The average price target represents a 29.48% change from the last price of $74.83.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"66":"$66","111":"$111","77.25":"$77.3","88.5":"$88.5","99.75":"$99.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":110,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$110.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":96.89,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$96.89</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[66,77.25,88.5,99.75,111],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.09,83.31384615384616,85.53769230769231,87.76153846153846,89.98538461538462,92.20923076923077,94.43307692307692,96.65692307692308,98.88076923076923,101.10461538461539,103.32846153846154,105.55230769230769,107.77615384615385,{"y":110,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.09,82.30538461538463,83.52076923076923,84.73615384615385,85.95153846153846,87.16692307692308,88.38230769230769,89.59769230769231,90.81307692307692,92.02846153846154,93.24384615384615,94.45923076923077,95.67461538461538,{"y":96.89,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.09,81.77538461538462,82.46076923076923,83.14615384615385,83.83153846153846,84.51692307692308,85.2023076923077,85.8876923076923,86.57307692307693,87.25846153846155,87.94384615384615,88.62923076923077,89.31461538461538,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":67.9,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.63,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.89,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.1,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.82,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.69,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.76,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.33,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.55,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.56,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.21,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.68,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.09,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$110.00Average Price Target$96.89Lowest Price Target$90.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on MET
TipRanks AITipRanks
Not Ranked
TipRanks
$85
Buy
13.59%
Upside
Reiterated
07/31/25
Metlife demonstrates strong financial performance and effective cash flow management, which are key drivers of its solid stock score. While technical analysis indicates potential bearish trends, the company's attractive valuation and positive earnings call sentiment provide a balanced outlook. Corporate events further support strategic growth, making Metlife a compelling investment in the life insurance industry.
Bank of America Securities Analyst forecast on MET
Joshua ShankerBank of America Securities
Bank of America Securities
Buy
Reiterated
07/15/25
Bank of America Securities Remains a Buy on Metlife (MET)
Evercore ISI Analyst forecast on MET
Thomas GallagherEvercore ISI
Evercore ISI
$110
Buy
47.00%
Upside
Reiterated
07/15/25
Evercore ISI Reaffirms Their Buy Rating on Metlife (MET)
Morgan Stanley Analyst forecast on MET
Bob HuangMorgan Stanley
Morgan Stanley
$99$98
Buy
30.96%
Upside
Reiterated
07/14/25
MetLife price target lowered to $98 from $99 at Morgan StanleyMetLife price target lowered to $98 from $99 at Morgan Stanley
Wells Fargo Analyst forecast on MET
Elyse GreenspanWells Fargo
Wells Fargo
$94$97
Buy
29.63%
Upside
Reiterated
07/10/25
MetLife price target raised to $97 from $94 at Wells FargoMetLife price target raised to $97 from $94 at Wells Fargo
KBW
$95$94
Buy
25.62%
Upside
Reiterated
07/09/25
KBW Sticks to Their Buy Rating for Metlife (MET)
J.P. Morgan Analyst forecast on MET
Jimmy BhullarJ.P. Morgan
J.P. Morgan
$86$95
Buy
26.95%
Upside
Reiterated
07/08/25
J.P. Morgan Reaffirms Their Buy Rating on Metlife (MET)
Barclays Analyst forecast on MET
Alex ScottBarclays
Barclays
$88$94
Buy
25.62%
Upside
Reiterated
07/07/25
MetLife price target raised to $94 from $88 at BarclaysMetLife price target raised to $94 from $88 at Barclays
Piper Sandler Analyst forecast on MET
John BarnidgePiper Sandler
Piper Sandler
$94
Buy
25.62%
Upside
Reiterated
07/03/25
Metlife (MET) Gets a Buy from Piper Sandler
Raymond James Analyst forecast on MET
Wilma BurdisRaymond James
Raymond James
Hold
Reiterated
06/30/25
Jefferies Analyst forecast on MET
Suneet KamathJefferies
Jefferies
$100
Buy
33.64%
Upside
Assigned
06/03/25
Metlife (MET) Receives a Buy from Jefferies
BMO Capital Analyst forecast on MET
Jack MattenBMO Capital
BMO Capital
$73$90
Hold
20.27%
Upside
Reiterated
05/20/25
BMO Capital Remains a Hold on Metlife (MET)
TD Cowen
$90
Buy
20.27%
Upside
Reiterated
05/01/25
Analysts' Top Financial Picks: TeraWulf Inc (WULF), Metlife (MET)
UBS
$98
Buy
30.96%
Upside
Reiterated
04/02/25
Metlife (MET) Receives a Rating Update from a Top Analyst
Argus Research Analyst forecast on MET
Kevin HealArgus Research
Argus Research
$93
Buy
24.28%
Upside
Reiterated
02/25/25
Argus Research Keeps Their Buy Rating on Metlife (MET)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on MET
TipRanks AITipRanks
Not Ranked
TipRanks
$85
Buy
13.59%
Upside
Reiterated
07/31/25
Metlife demonstrates strong financial performance and effective cash flow management, which are key drivers of its solid stock score. While technical analysis indicates potential bearish trends, the company's attractive valuation and positive earnings call sentiment provide a balanced outlook. Corporate events further support strategic growth, making Metlife a compelling investment in the life insurance industry.
Bank of America Securities Analyst forecast on MET
Joshua ShankerBank of America Securities
Bank of America Securities
Buy
Reiterated
07/15/25
Bank of America Securities Remains a Buy on Metlife (MET)
Evercore ISI Analyst forecast on MET
Thomas GallagherEvercore ISI
Evercore ISI
$110
Buy
47.00%
Upside
Reiterated
07/15/25
Evercore ISI Reaffirms Their Buy Rating on Metlife (MET)
Morgan Stanley Analyst forecast on MET
Bob HuangMorgan Stanley
Morgan Stanley
$99$98
Buy
30.96%
Upside
Reiterated
07/14/25
MetLife price target lowered to $98 from $99 at Morgan StanleyMetLife price target lowered to $98 from $99 at Morgan Stanley
Wells Fargo Analyst forecast on MET
Elyse GreenspanWells Fargo
Wells Fargo
$94$97
Buy
29.63%
Upside
Reiterated
07/10/25
MetLife price target raised to $97 from $94 at Wells FargoMetLife price target raised to $97 from $94 at Wells Fargo
KBW
$95$94
Buy
25.62%
Upside
Reiterated
07/09/25
KBW Sticks to Their Buy Rating for Metlife (MET)
J.P. Morgan Analyst forecast on MET
Jimmy BhullarJ.P. Morgan
J.P. Morgan
$86$95
Buy
26.95%
Upside
Reiterated
07/08/25
J.P. Morgan Reaffirms Their Buy Rating on Metlife (MET)
Barclays Analyst forecast on MET
Alex ScottBarclays
Barclays
$88$94
Buy
25.62%
Upside
Reiterated
07/07/25
MetLife price target raised to $94 from $88 at BarclaysMetLife price target raised to $94 from $88 at Barclays
Piper Sandler Analyst forecast on MET
John BarnidgePiper Sandler
Piper Sandler
$94
Buy
25.62%
Upside
Reiterated
07/03/25
Metlife (MET) Gets a Buy from Piper Sandler
Raymond James Analyst forecast on MET
Wilma BurdisRaymond James
Raymond James
Hold
Reiterated
06/30/25
Jefferies Analyst forecast on MET
Suneet KamathJefferies
Jefferies
$100
Buy
33.64%
Upside
Assigned
06/03/25
Metlife (MET) Receives a Buy from Jefferies
BMO Capital Analyst forecast on MET
Jack MattenBMO Capital
BMO Capital
$73$90
Hold
20.27%
Upside
Reiterated
05/20/25
BMO Capital Remains a Hold on Metlife (MET)
TD Cowen
$90
Buy
20.27%
Upside
Reiterated
05/01/25
Analysts' Top Financial Picks: TeraWulf Inc (WULF), Metlife (MET)
UBS
$98
Buy
30.96%
Upside
Reiterated
04/02/25
Metlife (MET) Receives a Rating Update from a Top Analyst
Argus Research Analyst forecast on MET
Kevin HealArgus Research
Argus Research
$93
Buy
24.28%
Upside
Reiterated
02/25/25
Argus Research Keeps Their Buy Rating on Metlife (MET)
Stocks with the Highest Top Analyst Consensus in the Financial Sector
Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Metlife

1 Month
xxx
Success Rate
23/34 ratings generated profit
68%
Average Return
+2.19%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 67.65% of your transactions generating a profit, with an average return of +2.19% per trade.
3 Months
xxx
Success Rate
21/34 ratings generated profit
62%
Average Return
+3.93%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.76% of your transactions generating a profit, with an average return of +3.93% per trade.
1 Year
Success Rate
23/30 ratings generated profit
77%
Average Return
+15.66%
reiterated a buy rating 28 days ago
Copying Ryan Krueger's trades and holding each position for 1 Year would result in 76.67% of your transactions generating a profit, with an average return of +15.66% per trade.
2 Years
xxx
Success Rate
24/31 ratings generated profit
77%
Average Return
+13.48%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 77.42% of your transactions generating a profit, with an average return of +13.48% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MET Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
0
0
Buy
19
23
22
24
32
Hold
1
0
1
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
23
23
27
35
In the current month, MET has received 32 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. MET average Analyst price target in the past 3 months is 96.89.
Each month's total comprises the sum of three months' worth of ratings.

MET Financial Forecast

MET Earnings Forecast

Next quarter’s earnings estimate for MET is $2.15 with a range of $2.02 to $2.45. The previous quarter’s EPS was $1.96. MET beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 65.64% of the time in the same period. In the last calendar year MET has Preformed in-line its overall industry.
Next quarter’s earnings estimate for MET is $2.15 with a range of $2.02 to $2.45. The previous quarter’s EPS was $1.96. MET beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 65.64% of the time in the same period. In the last calendar year MET has Preformed in-line its overall industry.

MET Sales Forecast

Next quarter’s sales forecast for MET is $18.53B with a range of $17.83B to $19.28B. The previous quarter’s sales results were $18.57B. MET beat its sales estimates 33.33% of the time in past 12 months, while its overall industry beat sales estimates 80.04% of the time in the same period. In the last calendar year MET has Outperformed its overall industry.
Next quarter’s sales forecast for MET is $18.53B with a range of $17.83B to $19.28B. The previous quarter’s sales results were $18.57B. MET beat its sales estimates 33.33% of the time in past 12 months, while its overall industry beat sales estimates 80.04% of the time in the same period. In the last calendar year MET has Outperformed its overall industry.

MET Stock Forecast FAQ

What is MET’s average 12-month price target, according to analysts?
Based on analyst ratings, Metlife’s 12-month average price target is 96.89.
    What is MET’s upside potential, based on the analysts’ average price target?
    Metlife has 29.48% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MET a Buy, Sell or Hold?
          Metlife has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Metlife’s price target?
            The average price target for Metlife is 96.89. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $110.00 ,the lowest forecast is $90.00. The average price target represents 29.48% Increase from the current price of $74.83.
              What do analysts say about Metlife?
              Metlife’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of MET?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis